VIMTA LABS
|
The Current P/S Ratio of VIMTA LABS is 8.82.
| Share Price | ₹666.4 | Oct 28,2025 |
| Market Cap | ₹2,965.3 Cr | |
| Sales-TTM | ₹336.1 Cr | TTM-Consolidated Results |
| Price/Sales | 8.82x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,965.3 Cr] as on Oct 28,2025
(/) Sales [ ₹336.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 8.82x ]
Thus, for VIMTA LABS , the investors are currently willing to pay '8.82 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VIMTA LABS | 336.1 | 8.82 | 2,965.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.53 | 404,804.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 17.69 | 170,764.0 |
| CIPLA LTD | 27,811.2 | 4.56 | 126,807.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.23 | 121,099.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.14 | 107,707.0 |
| MANKIND PHARMA LTD | 12,956.2 | 7.66 | 99,256.0 |
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.27 | 100,759.0 |
| LUPIN LTD | 23,375.9 | 3.75 | 87,750.6 |
| AUROBINDO PHARMA LTD | 32,024.8 | 1.99 | 63,862.0 |
| ABBOTT INDIA LTD | 6,589.9 | 9.61 | 63,319.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.99x |
| Max industry PS | 17.69x |
| Median industry PS | 7.53x |
| Average industry PS | 7.21x |
You may also like the below Video Courses